Literature DB >> 28667023

Autophagy-Inflammasome Interplay in Heart Failure: A Systematic Review on Basics, Pathways, and Therapeutic Perspectives.

Bonnie Chiu1,2, Eugeniu Jantuan2, Fan Shen2, Brian Chiu2, Consolato Sergi3,2,4.   

Abstract

Aging of the population contributes to the increasing prevalence of heart failure. Autophagy is an evolutionarily conserved process aiming to degrade both long-lived proteins and damaged or excessive cyto-organelles via the lysosomal-mediated pathway. Although autophagy is involved in the normal homeostasis of cardiovascular cells, upregulation of autophagy and its abnormal modulation by inflammation may lead to cardiovascular functional decline and heart failure. Despite major improvements in the prevention, diagnosis, and treatment of cardiovascular diseases, heart failure remains one of the major diagnostic and therapeutic challenges. Here, we review the cardiovascular autophagy and its interplay with inflammation which may lead to heart failure exploring some potential treatment options.
© 2017 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Autophagy; autophagy targeting therapy; cardiovascular diseases; heart failure; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28667023

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  5 in total

Review 1.  Cardiac effects and toxicity of chloroquine: a short update.

Authors:  Kanigula Mubagwa
Journal:  Int J Antimicrob Agents       Date:  2020-06-19       Impact factor: 5.283

Review 2.  Inflammasome and Mitophagy Connection in Health and Disease.

Authors:  Jae-Min Yuk; Prashanta Silwal; Eun-Kyeong Jo
Journal:  Int J Mol Sci       Date:  2020-07-01       Impact factor: 5.923

Review 3.  Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure.

Authors:  Consolato M Sergi
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

4.  NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection.

Authors:  Consolato M Sergi
Journal:  Vaccines (Basel)       Date:  2022-08-12

5.  Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Consolato M Sergi; Brian Chiu
Journal:  J Med Virol       Date:  2020-09-29       Impact factor: 20.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.